Platelet reactivity and hemorrhage risk in neurointerventional procedures under dual antiplatelet therapy

Last-Recorded P2Y12 Reaction Units Value Is Strongly Associated with Thromboembolic and Hemorrhagic Complications Occurring Up to 6 Months after Treatment in Patients with Cerebral Aneurysms Treated with the Pipeline Embolization Device

(2013) J.E. Delgado Almandoz et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Pre-procedure P2Y12 reaction units value predicts perioperative thromboembolic and hemorrhagic complications in patients with cerebral aneurysms treated with the Pipeline Embolization Device

(2013) Josser E Delgado Almandoz et al.   Journal of NeuroInterventional Surgery

Variability in initial response to standard clopidogrel therapy, delayed conversion to clopidogrel hyper-response, and associated thromboembolic and hemorrhagic complications in patients undergoing endovascular treatment of unruptured cerebral aneurysms

(2013) Josser E Delgado Almandoz et al.   Journal of NeuroInterventional Surgery

Usefulness of the VerifyNow P2Y12 assay to evaluate the antiplatelet effects of ticagrelor and clopidogrel therapies

(2012) Young-Hoon Jeong et al.   AMERICAN HEART JOURNAL

Clopidogrel Hyper-Response and Bleeding Risk in Neurointerventional Procedures

(2012) C. Goh et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

A Therapeutic Window for Platelet Reactivity for Patients Undergoing Elective Percutaneous Coronary Intervention

(2012) Fabio Mangiacapra et al.   JACC-Cardiovascular Interventions

Usefulness of Platelet Response to Clopidogrel by Point-of-Care Testing to Predict Bleeding Outcomes in Patients Undergoing Percutaneous Coronary Intervention (from the Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty-Bleeding Study)

(2011) Giuseppe Patti et al.   AMERICAN JOURNAL OF CARDIOLOGY

ACCF/AHA Clopidogrel Clinical Alert: Approaches to the FDA “Boxed Warning”

(2010) et al.   CIRCULATION

Assessment of P2Y12 inhibition with the point-of-care device VerifyNow P2Y12 in patients treated with prasugrel or clopidogrel coadministered with aspirin

(2009) Christoph Varenhorst et al.   AMERICAN HEART JOURNAL

Antiplatelet effects of clopidogrel and bleeding in patients undergoing coronary stent placement

(2009) D. SIBBING et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS